Streetbeat News

Stock Prices

EQIX

Equinix (NASDAQ:EQIX) has outperformed the market over the past 20 years, producing an average annual return of 21.46%. If an investor had bought $1000 of EQIX stock 20 years ago, it would be worth $48,470.11 today.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:00 pm

GOSS

Over the past 3 months, 5 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. The average price target is $5.4, implying an upside from the current price of $1.18. This represents a 22.86% decrease from the previous average price target of $7.00.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:00 pm

CB

Chubb (NYSE:CB) has outperformed the market over the past 15 years by 1.5% on an annualized basis, producing an average annual return of 10.14%. If an investor had bought $100 of CB stock 15 years ago, it would be worth $415.91 today.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:00 pm

IDYA

IDEAYA Biosciences (NASDAQ:IDYA) has received positive analyst ratings in the last quarter, with 1 bullish and 4 somewhat bullish ratings. The average 12-month price target for the company has increased by 8.62% to $34.4, with a high of $40.00 and a low of $32.00.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:00 pm

MU

Micron Technology Inc's shares are trading lower by 1.77% due to greater-than-expected inflation indicated by July PPI data. Higher inflation could increase production costs and squeeze Micron's profit margins. If inflation continues to exceed expectations, the Fed might consider raising interest rates, making borrowing more expensive for companies like Micron and impacting their investment plans.

Portfolio Pulse from Henry Khederian

August 11, 2023 | 5:57 pm

IVCP

HDL Therapeutics, a biotech company with an FDA-approved cardiovascular therapy, is set to merge with Swiftmerge Acquisition Corp. (NASDAQ:IVCP) in a $480 million business combination. The merger will accelerate the commercialization of HDL's innovative cardiovascular disease treatment. Post-merger, Swiftmerge will change its name to HDL Therapeutics, and the combined company will trade on the NASDAQ under the ticker symbol 'HDLT'. The transaction is expected to close in Q4 2023.

Portfolio Pulse from Happy Mohamed

August 11, 2023 | 5:55 pm

ARKK

BTCUSD

COIN

The U.S. Securities and Exchange Commission (SEC) has once again delayed its decision on the spot Bitcoin (CRYPTO: BTC) exchange-traded fund (ETF) proposed by ARK Investment Management. The SEC has initiated a 21-day public comment window for the ARK 21Shares Bitcoin ETF, marking another delay in the approval process. ARK's initial application was submitted in May, with the SEC having until January 2024 to finalize its stance. The SEC has previously rejected ARK's crypto ETF submissions, citing inadequate measures to prevent deceptive and manipulative activities.

Portfolio Pulse from Murtuza Merchant

August 11, 2023 | 5:47 pm

AMRS

CANO

MAXN

PTRA

YTEN

Several stocks experienced significant price movements in Friday's mid-day session. Amyris, Inc. (AMRS) and Proterra Inc. (PTRA) both filed for Chapter 11 bankruptcy, causing their shares to jump 179.1% and 37% respectively. Rigetti Computing, Inc. (RGTI), Telesat Corporation (TSAT), Ouster, Inc. (OUST), Evolv Technologies Holdings, Inc. (EVLV), Innodata Inc. (INOD), Apyx Medical Corporation (APYX), IonQ, Inc. (IONQ), 2U, Inc. (TWOU), Groupon, Inc. (GRPN), Bitdeer Technologies Group (BTDR), MicroCloud Hologram Inc. (HOLO), Tango Therapeutics, Inc. (TNGX), Eton Pharmaceuticals, Inc. (ETON), ModivCare Inc. (MODV), WeWork Inc. (WE), Arco Platform Limited (ARCE), Semler Scientific, Inc. (SMLR), Soho House & Co Inc. (SHCO), CleanSpark, Inc. (CLSK), Consolidated Water Co. Ltd. (CWCO), Apellis Pharmaceuticals, Inc. (APLS), Pagaya Technologies Ltd. (PGY), Erasca, Inc. (ERAS), NextNav Inc. (NN), and Holley Inc. (HLLY) all reported better-than-expected results, causing their shares to rise. Cano Health, Inc. (CANO) reported worse-than-expected results and is pursuing a sale process, causing its shares to dip 70.7%. Yield10 Bioscience, Inc. (YTEN) announced pricing of a $3.7 million public offering, causing its shares to fall 58.1%. Maxeon Solar Technologies, Ltd. (MAXN) reported mixed results and issued FY23 revenue guidance below estimates, causing its shares to fall 32%.

Portfolio Pulse from Lisa Levin

August 11, 2023 | 5:47 pm

CAT

A significant amount of unusual options activity has been observed for Caterpillar (NYSE:CAT), with a majority of investors taking a bearish stance. Whales have been targeting a price range from $220.0 to $300.0 for Caterpillar over the last 3 months. The current price of CAT is $284.83, up 0.36%. Analysts from Wells Fargo, Baird, Barclays, Goldman Sachs, and B of A Securities have maintained their ratings on Caterpillar, with price targets ranging from $234 to $323.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 5:46 pm

ABL

FGF

HIPO

ROOT

During Friday's intraday session, insurance stocks showed significant movement. Gainers included Abacus Life (ABL), Root (ROOT), Hagerty (HGTY), Reliance Global Group (RELI), BRP Group (BRP), and MBIA (MBI). Losers included Hippo Holdings (HIPO), FG Finl Gr (FGF), HCI Group (HCI), RenaissanceRe Holdings (RNR), RLI (RLI), and Vericity (VERY). The companies' recent Q2 earnings reports may have influenced these movements.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 5:40 pm